03880cam a2200541 i 4500 9781003451020 FlBoTFG 20251030122249.0 m o d cr cnu|||unuuu 240715s2025 flu go 000 0 eng d OCoLC-P eng rda pn OCoLC-P 9781003451020 (electronic bk.) 1003451020 (electronic bk.) 9781040105986 (electronic bk. : PDF) 104010598X (electronic bk. : PDF) 9781032583525 9781032586748 9781040105993 (electronic bk. : EPUB) 1040105998 (electronic bk. : EPUB) 10.1201/9781003451020 doi (OCoLC)1446216268 (OCoLC-P)1446216268 RC270.8 MED 012000 bisacsh TEC 059000 bisacsh TCB bicssc Malviya, Rishabha, author. Galgotias Uni. 65301 Emerging Roles of Nanocarrier in Cancer Therapy / Rishabha Maviya, Arun Kumar Singh, and Sonali Sundram. First edition. Boca Raton : CRC Press, 2025. 1 online resource (xiv, 180 pages). text txt rdacontent computer c rdamedia online resource cr rdacarrier Chapter 1: Nanomedicine as Cancer Therapeutics: Current Trends and OpportunitiesChapter 2: Technology Utilizing Nanoparticles in Treating CancerChapter 3: Targeted Therapy for Cancer with NanomedicineChapter 4: Effective Nanomedicine for cancer TherapyChapter 5: Enhancing Cancer Immunotherapy using Nanoparticle-Based Smart CarriersChapter 6: Opportunities and Challenges for Anticancer Nanomedicines based on Polymer-Drug Conjugates in Concurrent /combination treatmentChapter 7: siRNA Therapeutic Nanocarriers for the Treatment of CancerChapter 8: Boosting Nano Medicine Efficacy with Hyperbaric Oxygen TherapyChapter 9: Combo Nanomedicine: The Co-delivery of Multimodal Therapies for Effective, Targeted Plus Secure Treatment of CancerChapter 10: Multipurpose Micellar Nanomedicine for the Treatment of CancerChapter 11: Cellular Targeting using Nanoparticles for Targeted Cancer TherapyIndex This book addresses the limitations of existing therapeutic approaches using nanoparticles. Emerging Roles of Nanocarriers in Cancer Therapy will further provide information for the development of successful cancer nanomedicine therapies. Features Explains different types of nanoparticles, targeting mechanisms, and approved nanotherapeutics for oncological implications in cancer treatment. Covers in detail the characteristics of various nanotechnology-based drug delivery systems. Discusses passive and active cellular targeting, ligand-based targeting of nanoparticles, and strategies to improve nanoparticle-cellular membrane interaction. Presents the application of nanotherapeutics, current challenges, and prospects, and describes the path of future research. Highlights smart strategies for improving the clinical impact of cancer nanomedicine. The text is primarily written for graduate students, and academic researchers in the fields of biotechnology, nanotechnology, drug delivery, pharmaceutical science, and pharmacology. OCLC-licensed vendor bibliographic record. Cancer Treatment. 63722 MEDICAL / Chemotherapy bisacsh 94740 Singh, Arun Kumar, author. 94741 Sundram, Sonali, author. 65302 Taylor & Francis https://www.taylorfrancis.com/books/9781003451020 OCLC metadata license agreement http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf E-Books 67876 67876